Preliminary observations from a Phase III clinical trial (NCT02896192) suggested that among 10 patients with POMC -deficient obesity (aged 6 years, BMI 30 kg/m 2 ), approximately 80% achieved a weight reduction of 10% after 1 year of treatment with setmelanotide following individualized dose titration
You measure your dose using an oral syringe, place the liquid under your tongue, hold it there for a minimum of two minutes, and then swallow whatever remains
But LifeRx needs to clean up its front-of-house experience to match the quality of whats behind it
Dual and triple incretin-based co-agonists: novel therapeutics for obesity and diabetes
Future direction The evolution of GLP-1RAs is increasingly shifting toward oral formulations, aiming to enhance patient adherence by eliminating the need for injections and addressing the logistical complexities associated with traditional peptide therapies [72, 73]
The biggest mistake I see is people trying to outwork the fatigue